Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma Reply

DA Fennell; P Taylor; D Gilligan; T Nakano; A Scherpereel; N Pavlakis; JP van Meerbeeck; Joachim Aerts; AK Nowak; H Kindler; P Baas

doi:10.1200/jco.19.01208

Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma Reply

DA Fennell, P Taylor, D Gilligan, T Nakano, A Scherpereel, N Pavlakis, JP van Meerbeeck, Joachim Aerts, AK Nowak, H Kindler, P Baas

Pulmonary Medicine

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2294-+
Journal	Journal of Clinical Oncology
Volume	37
Issue number	25
DOIs	https://doi.org/10.1200/jco.19.01208
Publication status	Published - 2019

Research programs

EMC MM-04-42-02

Access to Document

10.1200/jco.19.01208

http://hdl.handle.net/1765/121020

Cite this

@article{9431ab0bd9f04706ac508f46e3adfe0d,

title = "Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma Reply",

author = "DA Fennell and P Taylor and D Gilligan and T Nakano and A Scherpereel and N Pavlakis and \{van Meerbeeck\}, JP and Joachim Aerts and AK Nowak and H Kindler and P Baas",

year = "2019",

doi = "10.1200/jco.19.01208",

language = "Undefined/Unknown",

volume = "37",

pages = "2294--+",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "25",

}

TY - JOUR

T1 - Questions Regarding the Randomized Phase II Trial of Defactinib as Maintenance Therapy in Malignant Pleural Mesothelioma Reply

AU - Fennell, DA

AU - Taylor, P

AU - Gilligan, D

AU - Nakano, T

AU - Scherpereel, A

AU - Pavlakis, N

AU - van Meerbeeck, JP

AU - Aerts, Joachim

AU - Nowak, AK

AU - Kindler, H

AU - Baas, P

PY - 2019

Y1 - 2019

U2 - 10.1200/jco.19.01208

DO - 10.1200/jco.19.01208

M3 - Article

SN - 0732-183X

VL - 37

SP - 2294-+

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 25

ER -